GMO Europe LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
GMO Europe LLC
CRD #169308
SEC #801-78683
CIK #
AUM
Employees 13 (46% Investors, 15% Brokers)
Fees
Minimum
Phone617-330-7500
Address40 Rowes Wharf
Boston, MA 02110
Source [IAPD] [Website]
Total AUM ($B)
5.04.03.02.01.00.02009201420192025
Fees and Compensation — Form ADV Part 2A (3/29/2019) [Brochure]
Item 5.      Fees and Compensation

A. The rate of GMOE’s advisory (or management) fee varies with the type of product or asset
   class being managed, the investment strategy being employed, and the vehicle type in which
   the strategy is being implemented. GMOE’s fees are primarily asset-based and calculated at
   an annual rate as a percentage of the value of the net assets in the account.

    In some cases, GMOE may be paid a combination of an asset-based fee and a performance
    fee. The performance fee may take the form of a special allocation of profit to GMO, or an
    affiliate, from a GMO pooled vehicle. (Special allocation and performance-based fees or
    performance fees are referred to interchangeably throughout this brochure.) The performance
    fee may be calculated in a variety of ways depending on multiple factors including, but not
    limited to, the nature of the strategy, relevant performance benchmarks and performance

38523174_4

   hurdles, and is generally calculated based on both realized and unrealized amounts. Please
   see Item 6, “Performance-Based Fees and Side-by-Side Management” for more information.

   Under appropriate circumstances, in GMOE’s discretion and where permitted by applicable
   law, the terms of an investment advisory contract, including fee schedules, terms of payment
   and termination provisions, may be negotiable. GMOE may, for fee calculation purposes,
   agree to aggregate the assets of related accounts that are being managed for the same client,
   even if such account(s) is/are managed by an affiliate of GMOE. In those circumstances, the
   aggregate accounts may receive the benefit of a lower effective fee due to the combined level
   of assets.

   The GMO Funds pay management fees to GMOE and bear total net annual expenses as
   described in the attached Schedule I and as described in their respective prospectuses, as
   supplemented and/or amended from time to time.

   With respect to the fees paid by the GMO Funds, GMOE has discretion to waive, reduce or
   rebate a portion of the asset-based fees and/or performance fees for any period for some or all
   investors. GMOE also has discretion to admit investors or accept additional subscriptions
   from existing investors subject to such other fee arrangements as it deems appropriate and
   generally without notice to or consent from other investors. Note that this summary of fees is
   as of March 15, 2019 and may not reflect subsequent changes.

B. Fees are accrued daily or monthly and generally paid in arrears. The amount of the asset-
   based fee is prorated if GMOE provides advisory services for periods of less than a full
   payment cycle (e.g., at the beginning or end of GMOE’s engagement to provide advisory
   services). For accounts with performance fees, performance fee payment obligations are
   generally triggered by redeeming from a GMO Fund and at the end of an account’s
   performance-measurement period (typically, annually). GMOE requires that fees be paid
   within the calendar year in which they were billed, and with respect to fees billed as of
   December 31 of each year, no later than December 31 of the following year.

C. In the event GMOE manages a separately managed account, such client will incur brokerage
   costs, third-party execution costs (if any) and other transaction costs associated with
   GMOE’s management of the accounts’ portfolio securities. Please see Item 12, “Brokerage
   Practices” for a description of GMOE’s brokerage practices.

   In addition to advisory fees, clients invested in the GMO Funds, whether directly or through
   a separately managed account, will bear the other fees and expenses paid by the GMO Funds
   (to the extent not otherwise waived or reimbursed by GMOE), including but not limited to
   custody fees, brokerage commissions and third-party execution fees, if any, administration,
   legal, audit, tax, accounting, and certain other fees and expenses, which may include interest
   costs, commitment costs, purchase premium, redemption or other charges, other investment
   related costs (including investment-related legal and tax expenses and overdraft charges), and
   extraordinary, non-recurring and certain other unusual expenses such as taxes and non-U.S.
   investment related costs (including, without limitation, associated local legal, tax and
   accounting costs). Some GMO Funds also charge purchase premiums and/or redemption

   fees, which are paid by the investor to the relevant GMO Fund (and not to GMOE) upon
   purchases into, or redemptions from, such GMO Fund.

   GMOE has contractually agreed to bear some of the operational expenses for some of the
   GMO Funds it advises (e.g., accounting and transfer agency expenses). The extent to which
   GMOE bears those expenses varies by GMO Fund. Therefore, when negotiating those
   expenses with third-party service providers (which may be negotiated for all pools advised
   by GMOE and its affiliates at the same time), GMOE has an economic incentive to favor a
   fee structure that shifts expenses from funds for which GMOE or one of its affiliates has a
   greater reimbursement obligation to those funds for which GMOE or its affiliate has a lesser
   (or no) reimbursement obligation. Further, to the extent that GMOE has discretion to allocate
   a client’s assets among GMO Funds, it has an incentive to allocate to GMO Funds where it
   has a limited reimbursement obligation.

D. Clients do not pay GMOE’s fees in advance.

E. Neither GMOE nor any of its supervised persons accepts compensation for the sale of
   securities or other investment products.
Account Minimums and Types of Clients — Form ADV Part 2A (3/29/2019) [Brochure]
Item 7.   Types of Clients

   As described in Item 5, “Fees and Compensation” GMOE provides investment advice
   primarily to the GMO Funds, but may also provide investment advice to institutional clients.

   Clients of GMOE and/or investors invested in the GMO Funds may include, but are not
   limited to, endowments and foundations; employee benefit, pension and contribution plans;
   governmental and supranational entities; family offices; high net worth individuals; taxable
   entities; investment companies; pooled investment vehicles; trusts; other institutions and
   individuals (including individual retirement accounts). The minimum account size for
   investors in the GMO Funds varies depending on the GMO Fund, but is generally at least $5
   million and there are generally legal and/or regulatory based limitations on the types of
   eligible investors. Minimum account size requirements are waived for GMO’s Members and
   GMOE’s and its affiliates’ employees and for other investors at GMOE’s discretion. GMOE
   may waive a Fund’s investment minimum for clients whose investment consultant has full
   discretion or exercises substantial influence over its clients’ assets and where the relationship
   meets the investment minimum.
Type Form D Funds Date Sold AUM
HF GMO Mean Reversion Special Solution Fund LP 2015-02-04 822.5 M
HF GMO World Equity Allocation Investment Fund PLC [2012-03-30] 19.7 M 457.5 M
Filed 2017-04-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 4.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 4 4.2
By Discretionary
Discretionary 4 4.2
Non-Discretionary 0 0.0
Total 4 4.2
By Non-United States Persons
Non-United States Persons 4.2
United States Persons 0.0
Total 4 4.2
Limited Partners2011 - 2026
Maine Public Employees Retirement System
Teachers' Retirement System of the City of New York
Virginia Retirement System
Form D Directors Role # Filings # Firms 2011 - 2026
Eimear Cowhey Director 21 7
David Bohan Director 53 3
John Fitzpatrick Director 16 3
Arron Day Director 10 3
Jay Lyons Director 7 3
Gavin Flaxman Director 5 2
Firm Profile (Form ADV)
Discretionary AUM$2.5B
ServesInstitutional
Fund TypesHedge Fund
Related Firms State AUM
Grantham Mayo van Otterloo & Co LLC
MA 80.97 B
GMO Europe LLC
MA
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com